UNICREDIT BANK/CALL/AMGEN/280/0.1/15.01.25 | Market Closed - BOERSE MUENCHEN 03:41:11 2024-07-16 pm EDT | ||
| 5.86 EUR | +2.99% |
|
| Current month | +32.58% | ||
| 1 month | +63.69% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-16 | 5.86 | +2.99% |
| 24-07-15 | 5.69 | -2.23% |
| 24-07-12 | 5.82 | +10.65% |
| 24-07-11 | 5.26 | +6.05% |
| 24-07-10 | 4.96 | +9.73% |
Real-time BOERSE MUENCHEN
Last update July 16, 2024 at 03:41 pm EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HC4EFN |
| ISIN | DE000HC4EFN4 |
| Date issued | 2023-02-23 |
| Strike | 280 $ |
| Maturity | 2025-01-15 (183 Days) |
| Parity | 10 : 1 |
| Emission price | 1.88 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.97 € |
|---|---|
| Lowest since issue | 0.77 € |
| Spread | 0.02 € |
| Spread % | 0.34% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
333.1
USD
Average target price
317.4
USD
Spread / Average Target
-4.72%
- Stock Market
- Warrants
- Warrant
